# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-25-005332
Filing Date
2025-04-24
Accepted
2025-04-24 07:00:16
Documents
21
Period of Report
2025-06-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | acrs-20250605xdef14a.htm iXBRL | DEF 14A | 1261451
2 | GRAPHIC | acrs-20250605xdef14a_a001.jpg | GRAPHIC | 3610
3 | GRAPHIC | acrs-20250605xdef14a_a016.jpg | GRAPHIC | 35181
4 | GRAPHIC | acrs-20250605xdef14a_a017.jpg | GRAPHIC | 36367
5 | GRAPHIC | acrs-20250605xdef14a_bg001.jpg | GRAPHIC | 143671
6 | GRAPHIC | acrs-20250605xdef14a_bg002.jpg | GRAPHIC | 93798
| Complete submission text file | 0001558370-25-005332.txt |  | 3231194

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | EX-101.SCH | acrs-20250605.xsd | EX-101.SCH | 4595
8 | EX-101.DEF | acrs-20250605_def.xml | EX-101.DEF | 3846
9 | EX-101.LAB | acrs-20250605_lab.xml | EX-101.LAB | 6752
10 | EX-101.PRE | acrs-20250605_pre.xml | EX-101.PRE | 6061
23 | EXTRACTED XBRL INSTANCE DOCUMENT | acrs-20250605xdef14a_htm.xml | XML | 412032

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37581 | Film No.: 25863523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)